Immuron IMRN
NASDAQ IMRN
$1.12 -0.06 (-5.08%)
As of: Aug 21, 2026 · 3:58 PM EDT

Immuron (IMRN) Gross Profit (2016 - 2024)

Immuron (IMRN) posted quarterly Gross Profit of -$1737594727.2 billion for Q4 2024, down 109950132958505.31% year-over-year from N/an in Q1 2024, and down 109950132958505.31% quarter-over-quarter from $1.6 million in Q4 2023.

Immuron (IMRN) Gross Profit (2016 - 2024) Analysis & Trends

Immuron's Gross Profit history runs 9 years deep, the most recent figure standing at -$1737594727.2 billion for Q4 2024.

  • In Q4 2024, Gross Profit fell 109950132958505.31% year-over-year to -$1737594727.2 billion; the TTM figure through Dec 2024 stood at -$1737594727.2 billion (down 83615319075966.94% YoY), while the FY2025 annual figure was $3.1 million, up 41.12% from the prior year.
  • Gross Profit for Q4 2024 stood at -$1737594727.2 billion, down from $1.6 million in the prior quarter.
  • The five-year high for Gross Profit was $1.6 million in Q4 2023, with the low at -$1737594727.2 billion in Q4 2024.
  • The 5-year median for Gross Profit is $37143.9 (2020), against an average of -$289599121.2 billion.
  • The sharpest annual moves came in 2022 and 2024: Gross Profit jumped 36086.56% in 2022, then plunged 109950132958505.31% in 2024.
  • Immuron's Gross Profit stood at $5656.6 in 2020, then tumbled by 79.09% to $1182.5 in 2021, then surged by 36086.56% to $427920.0 in 2022, then jumped by 269.31% to $1.6 million in 2023, then slumped by 109950132958505.31% to -$1737594727.2 billion in 2024.
  • Business Quant data shows IMRN's Gross Profit at -$1737594727.2 billion in Q4 2024, $1.6 million in Q4 2023, and $68631.3 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Immuron 6.75 Mn 6.73 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -1,737,594,727.21 Bn
Dec 31, 2024 -1,737,594,727.21 Bn
Dec 31, 2023 1.58 Mn
Dec 31, 2023 1.58 Mn
Jun 30, 2023 68,631.26
Jun 30, 2023 68,631.26
Dec 31, 2022 427,920.00
Dec 31, 2022 427,920.00
Dec 31, 2021 1,182.54
Dec 31, 2021 1,182.54
Dec 31, 2020 5,656.57
Dec 31, 2020 5,656.57
Dec 31, 2019 11,214.25
Dec 31, 2019 11,214.25
Dec 31, 2018 746,754.00
Dec 31, 2018 746,754.00
Dec 31, 2017 564,074.12
Dec 31, 2017 564,074.12
Dec 31, 2016 361,687.03
Dec 31, 2016 361,687.03